Carson Wealth (CWM LLC)
GCVRZ

Carson Wealth (CWM LLC)’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-114
Closed – – 3526
2018
Q4 		$0 Hold
114
– – ﹤0.01% 2377
2018
Q3 		$0 Hold
114
– – ﹤0.01% 2102
2018
Q2 		$0 Hold
114
– – ﹤0.01% 1851
2018
Q1 		$0 Hold
114
– – ﹤0.01% 1649
2017
Q4 		$0 Buy
114
+100
+714% +$38 ﹤0.01% 1667
2017
Q3 		$0 Hold
14
– – ﹤0.01% 1646
2017
Q2 		$0 Buy
+14
New +$6 ﹤0.01% 1400

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Carson Wealth (CWM LLC)'s GCVRZ Position: Q1 2019 in Review

Carson Wealth (CWM LLC) sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2019, closing a stake of 114 shares.

Carson Wealth (CWM LLC) first reported a position in GCVRZ in Q2 2017 and held it in 7 quarters. The position peaked at $0 in Q4 2018. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2019.

  • Carson Wealth (CWM LLC) reported no remaining Sanofi Contingent Value Rights position as of Q1 2019 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 114 Sanofi Contingent Value Rights shares in Q1 2019.
  • Carson Wealth (CWM LLC) first reported a position in Sanofi Contingent Value Rights in Q2 2017 and held it in 7 quarters.
  • Carson Wealth (CWM LLC)'s Sanofi Contingent Value Rights position peaked at $0 in Q4 2018.
  • 105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2019.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2019, filed 22 Apr 2019.